Evercore Inc. EVR
297.66 USD -5.60 (-1.85%)
Nov 3, 2026, 3:25 PM EST
297.58 Day range 306.73
245.47 52-week range 388.71
- YTD
- -12.52%
- 1 year
- -0.85%
Analyst view
Consensus: buy
Buy
Price target (mean) 344.80 +15.8% upside
Now 297.66
- Target (low)
- 285.00
- Target (mean)
- 344.80
- Target (high)
- 391.00
Ratings (0m) 11 6 buy · 5 hold · 0 sell
- Strong buy1
- Buy5
- Hold5
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 5.23 | 4.62 – 5.70 | 5.13 | +2.0% | 1.35B | +3.7% | 9 |
| Next quarter | 5.45 | 4.71 – 6.18 | 7.53 | -27.7% | 1.17B | -16.5% | 8 |
| Current year | 19.97 | 19.34 – 20.46 | 14.56 | +37.2% | 4.91B | +26.5% | 10 |
| Next year | 21.32 | 19.50 – 24.13 | 19.97 | +6.8% | 5.31B | +8.1% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 8, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 7, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 1, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Aug 3, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Jul 30, 2026 | UBS | Maintained | Neutral | Neutral |
| Jul 30, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 30, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jul 10, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jul 8, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 30, 2026 | UBS | Maintained | Neutral | Neutral |
| Apr 14, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Apr 9, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 1, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Mar 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Mar 12, 2026 | Goldman Sachs | Maintained | Buy | Buy |
| Feb 5, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 5, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Feb 5, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jan 8, 2026 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Jan 7, 2026 | UBS | Maintained | Neutral | Neutral |
| Jan 6, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Dec 17, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Dec 8, 2025 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Oct 30, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 30, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Oct 13, 2025 | Keefe, Bruyette & Woods | Maintained | Outperform | Outperform |
| Oct 9, 2025 | Deutsche Bank | Initiated | — | Buy |
| Oct 3, 2025 | BMO Capital | Initiated | — | Market Perform |